Cardiovascular risk management in cancer survivors: Are we doing it right?
| Autor: | Turab Mohammed, Tarang Parekh, Aakash Desai |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Opinion Review
0301 basic medicine medicine.medical_specialty Cancer survivors Primary care Childhood Cancer Survivor Study Disease 03 medical and health sciences 0302 clinical medicine Intervention (counseling) medicine Intensive care medicine Risk management business.industry Cancer Childhood cancer survivor study Atherosclerotic cardiovascular disease risk estimator Cardiovascular disease risk medicine.disease Cardio-oncology 030104 developmental biology Increased risk Oncology 030220 oncology & carcinogenesis Cancer policy business Risk assessment |
| Zdroj: | World Journal of Clinical Oncology |
| ISSN: | 2218-4333 |
| DOI: | 10.5306/wjco.v12.i3.144 |
| Popis: | Although under-recognized, cancer survivors continue to be at an increased risk of death from cardiovascular complications post-remission or cure. This increased burden of cardiovascular disease results from the interplay of various factors. Adequate cardiovascular risk assessment and timely intervention through a multi-disciplinary approach in these patients plays a pivotal role in the prevention of cardiovascular morbidity and mortality. We discuss the shortcomings of using current risk prediction scores in cancer survivors and provide some insights into cardiovascular risk management relevant for primary care physicians, oncologists, and cardiologists alike. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|